ClearPoint Neuro, Inc. (CLPT) Stock Overview
Explore ClearPoint Neuro, Inc.’s financial performance, market position, analyst ratings, and future outlook.
ClearPoint Neuro, Inc. (CLPT)
Key Financials
Key Financials
Market Cap
462.4M
P/E Ratio
-13.06
EPS (TTM)
$-1.18
ROE
-1.88%
CLPT Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of ClearPoint Neuro, Inc. (NASDAQ: CLPT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, ClearPoint Neuro, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of CLPT on the NASDAQ shows an RSI of 53.78, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $17.85 for the NASDAQ listing.
Key metrics behind ClearPoint Neuro, Inc.'s NASDAQ-traded stock include a P/E ratio of -13.06 and a market capitalization of 462.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CLPT on the NASDAQ.